Volume 30 Number 4
Editorial
Christian Moro
Licensed under CC BY 4.0
For referencing Moro C. Editorial. Australian and New Zealand Continence Journal. 2024;30(4):86.
DOI 10.33235/anzcj.30.4.86
We are delighted to present the final edition of the Australian and New Zealand Continence Journal for 2024. Our big news is that the journal will be transferring to a new publisher next year. CSIRO Publishing is a not-for-profit business unit that operates within Australia’s national science agency, CSIRO. They will work in collaboration with our editorial board to support international discoverability and the journal’s growth, while facilitating a high quality of author care. To learn more about the CSIRO Publishing journal program visit their website. We would like to thank our current publisher, Cambridge Media, for their support over the many decades we have worked together.
The Journal’s content will be accessible from the CSIRO Publishing website in January 2025, and we will let you know as soon as the new ScholarOne author submission portal is live. We are certainly very excited for this next step in supporting the journal’s growth and impact through our collaboration with CSIRO Publishing. This will not impact our publication schedule and we continue to welcome submissions to the journal. Please reach out to us journal@continence.org.au if you have any queries or questions about the publication process.
Our first article in this current edition is about conservative management of Type III A/B chronic prostatitis/chronic pelvic pain syndrome. 1 This study undertakes a broad literature investigation to identify whether there is sufficient research evidence to recommend any one intervention over another for this chronic condition.
Our second article is about the effects of home transcutaneous electrical nerve stimulation for children with overactive bladder syndrome. 2 In this original research project, the authors collected data from children who experienced symptoms of overactive bladder, providing insights into whether transcutaneous electrical nerve stimulation that is administered at home can be an effective treatment option.
Our third article is in our ‘Did You Know’ segment, titled: Did you know... 43.5% of New Zealand women between the ages of 16 and 74 report at least some urinary incontinence. 3 It provides some statistics and insights into the prevalence of continence in New Zealand.
We hope you enjoy the articles as much as our team did during the reviewing and editorial phases.
Author(s)
Christian Moro
Editor-In-Chief and Chair
Australian and New Zealand Continence Journal
References
- Hon RY, et al. Conservative management of Type III A/B chronic prostatitis/chronic pelvic pain Syndrome: a systematic review. Australian and New Zealand Continence Journal. 2024;30(4):87-104.
- Hamilton S, et al. A study of the effects of home administered transcutaneous electrical nerve stimulation on quality of life, psychosocial and incontinence outcomes in children with overactive bladder syndrome. Australian and New Zealand Continence Journal. 2024;30(4):105-111.
- Weatherall M. Did you know...that 43.5% of New Zealand women report at least some urinary incontinence? Australian and New Zealand Continence Journal. 2024;30(4):112.